Big Pharma's competition to buy new cancer drugs

Aug 22, 2016
Pfizer spends $14 billion for a new prostate cancer drug plus others in the pipeline

Need some Econ 101?

Our new Marketplace Crash Course is here to help. Sign-up for free, learn at your own pace.